ReflexMD charges $299/month for compounded semaglutide and $399/month for tirzepatide. We compared seven checkout-verified telehealth providers to identify which offer lower ongoing rates, prepaid discounts, and transparent pricing structures—including annual cost calculations for each alternative.

ReflexMD publishes $299/month for compounded semaglutide and $399/month for tirzepatide, both month-to-month with no membership fee. We verify what's included and compare head-to-head with PlexusDx.

PlexusDx charges $189/month for compounded semaglutide injection and $289/month for tirzepatide injection on month-to-month billing. ReflexMD charges $299/month for semaglutide and $399/month for tirzepatide. Both operate without membership fees or long-term contracts.

ReflexMD charges $299/month for compounded semaglutide and $399/month for tirzepatide on standard ongoing billing. PlexusDx offers the same compounded injections at $189/month and $289/month respectively, a $110/month reduction on either medication with no membership fee.

PlexusDx and ReflexMD both offer compounded semaglutide and tirzepatide injections plus oral weight-loss medications. At the month-to-month level, PlexusDx lists semaglutide at $189 versus ReflexMD's $299 and tirzepatide at $289 versus $399.

Both Reflexmd and Henry Meds offer telemedicine GLP-1 access, but they differ in pricing, pharmacy partnerships, and clinical oversight models. This comparison helps patients understand sourcing, provider involvement, and how to align their choice with clinical evidence and personal health context.

Is ReflexMD legit? This independent editorial review looks past star ratings to the signals that actually establish legitimacy in GLP-1 telehealth: licensed clinicians, a real 503A compounding pathway, and verifiable oversight, plus the genetic context that a telehealth prescription alone can never provide before you enroll.

Understanding the ReflexMD pricing model matters more than fixating on any single figure. This independent editorial review examines the subscription structure, billing cadence, what is bundled versus itemized, and compounded versus branded pathways, then adds the upstream genetic context that most telehealth programs overlook entirely.

The ReflexMD price you first see is not always the price you keep paying month after month. This independent editorial review explains promotional versus ongoing rates, per-dose versus per-month framing, why a firm quote appears only after intake, and how transparent flat pricing compares against it.

ReflexMD cost rarely reduces to one figure. This independent editorial review breaks a compounded GLP-1 month into its parts, shows what pushes the total up or down, explains why insurance seldom applies, and adds the genetic context most telehealth programs leave out.

Tirzepatide is a dual GIP/GLP-1 agonist, and how a telehealth program handles it matters. This independent editorial review explains the mechanism, compounded versus branded supply, the SURMOUNT trial evidence, and the pathway-level genetics that shape the terrain tirzepatide acts on.

Reflexmd is a telemedicine provider offering semaglutide prescriptions through remote consultations. This article examines clinical evidence for semaglutide efficacy, how provider selection affects outcomes, and what patients should evaluate when choosing a semaglutide program.

Henry Meds and Reflexmd both offer remote GLP-1 access, but differ in eligibility criteria, pricing structures, and clinical evaluation depth.

ReflexMD reviews can guide or mislead depending on how you read them. This independent editorial review explains what online ratings capture, what they leave out, how to separate service feedback from medication outcomes, and why your own biology matters more than any star count.

Reflexmd offers telehealth-based GLP-1 medication access with provider oversight, but understanding genetic predispositions and biomarkers can help patients make more informed decisions about whether compounded or branded options align with their clinical profile.